SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882104-20-000210
Filing Date
2020-12-17
Accepted
2020-12-17 16:48:55
Documents
1
Period of Report
2020-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_160824171593782.html 4  
1 FORM 4 wf-form4_160824171593782.xml 4 3067
  Complete submission text file 0000882104-20-000210.txt   4553
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O ALEXION PHARMACEUTICALS, INC. 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Monnet Dominique (Reporting) CIK: 0001632798 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 201396664